309 related articles for article (PubMed ID: 2201096)
1. Flow cytometry and prognostic implications in patients with solid tumors.
Williams NN; Daly JM
Surg Gynecol Obstet; 1990 Sep; 171(3):257-66. PubMed ID: 2201096
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
Miao T; Wang Z; Sang N; Xiong R; Cao S
Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
[TBL] [Abstract][Full Text] [Related]
3. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic significance of DNA content in transitional cell carcinoma of the urinary bladder].
Sun X
Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):24-6. PubMed ID: 1396041
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
8. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
Toyota K
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
[TBL] [Abstract][Full Text] [Related]
9. [The clinical significance of flow cytometric DNA measurement of paraffin specimen in bladder tumor].
Wang Z
Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):505-8, 512. PubMed ID: 2086120
[TBL] [Abstract][Full Text] [Related]
10. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
[TBL] [Abstract][Full Text] [Related]
13. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy and survival in breast cancer patients.
Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
[TBL] [Abstract][Full Text] [Related]
15. [The DNA content of bladder carcinoma in relation to pathologic grading, staging and prognosis: a flow cytometric study].
Xue J
Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):650-3, 700. PubMed ID: 2632194
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
17. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
[TBL] [Abstract][Full Text] [Related]
18. [DNA profile, recurrence rate and progression of superficial G2 cancer of the urinary bladder].
Maier G; Heissler HE; Blech M; Schröter W
Urologe A; 1988 May; 27(3):173-6. PubMed ID: 3407050
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211
[TBL] [Abstract][Full Text] [Related]
20. Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology Group.
Fradet Y; Tardif M; Bourget L; Robert J
Cancer Res; 1990 Jan; 50(2):432-7. PubMed ID: 2295082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
